Clinical and pathophysiological characteristics of cirrhotic patients with grade 1 and minimal hepatic encephalopathy

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Thomsen, Karen Louise ^a   Macnaughtan, Jane ^a   Tritto, Giovanni ^a   Mookerjee, Rajeshwar P ^a   Jalan, Rajiv ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; BACTERIAL DNA;

ADULT; AMMONIA BLOOD LEVEL; ARTICLE; BACTERIAL TRANSLOCATION; BIOCHEMISTRY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HOSPITALIZATION; HUMAN; INFECTION; LIVER CIRRHOSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NEUTROPHIL; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RESPIRATORY BURST; AGED; BACTEREMIA; BLOOD; COMPLICATION; LIVER; METABOLISM; MICROBIOLOGY; NOMENCLATURE; PATHOLOGY; PRACTICE GUIDELINE; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

AGED; AMMONIA; BACTEREMIA; BACTERIAL TRANSLOCATION; DNA, BACTERIAL; FEMALE; HEPATIC ENCEPHALOPATHY; HOSPITALIZATION; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NEUTROPHILS; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; RESPIRATORY BURST; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TERMINOLOGY AS TOPIC;

EID: 84954348960     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0146076     Document Type: Article

References (37)

1. Cordoba J, Ventura-Cots M, Simon-Talero M, Amoros A, Pavesi M, Vilstrup H, et al. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). J Hepatol. 2014; 60(2):275-81. doi: 10.1016/j.jhep.2013.10.004 PMID: 24128414.
2. Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol. 1999; 30(5):890-5. PMID: 10365817.
3. Jepsen P, Ott P, Andersen PK, Sorensen HT, Vilstrup H. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology. 2010; 51(5):1675-82. doi: 10.1002/hep.23500 PMID: 20186844.
4. Stewart CA, Malinchoc M, Kim WR, Kamath PS. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl. 2007; 13(10):1366-71. doi: 10.1002/lt.21129 PMID: 17520742.
5. Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol. 2001; 96(9):2718-23. doi: 10.1111/j.1572-0241.2001.04130.x PMID: 11569701.
6. Hartmann IJ, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC, et al. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol. 2000; 95(8):2029-34. doi: 10.1111/j. 1572-0241.2000.02265.x PMID: 10950053.
7. Ortiz M, Jacas C, Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol. 2005; 42 Suppl(1):S45-53. doi: 10.1016/j.jhep.2004.11.028 PMID: 15777572.
8. American Association for the Study of Liver D, European Association for the Study of the L. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol. 2014; 61 (3):642-59. doi: 10.1016/j.jhep.2014.05.042 PMID: 25015420.
9. Bajaj JS, Cordoba J, Mullen KD, Amodio P, Shawcross DL, Butterworth RF, et al. Review article: the design of clinical trials in hepatic encephalopathy-an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther. 2011; 33 (7):739-47. doi: 10.1111/j.1365-2036.2011.04590.x PMID: 21306407; PubMed Central PMCID: PMC3971432.
10. Mookerjee RP, Stadlbauer V, Lidder S, Wright GA, Hodges SJ, Davies NA, et al. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. Hepatology. 2007; 46(3):831-40. doi: 10.1002/hep.21737 PMID: 17680644.
11. Shawcross DL, Wright GA, Stadlbauer V, Hodges SJ, Davies NA, Wheeler-Jones C, et al. Ammonia impairs neutrophil phagocytic function in liver disease. Hepatology. 2008; 48(4):1202-12. doi: 10.1002/hep.22474 PMID: 18697192.
12. Ong JP, Aggarwal A, Krieger D, Easley KA, Karafa MT, Van Lente F, et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med. 2003; 114(3):188-93. PMID: 12637132.
13. Tranah TH, Vijay GK, Ryan JM, Shawcross DL. Systemic inflammation and ammonia in hepatic encephalopathy. Metab Brain Dis. 2013; 28(1):1-5. doi: 10.1007/s11011-012-9370-2 PMID: 23224356.
14. Shawcross DL, Sharifi Y, Canavan JB, Yeoman AD, Abeles RD, Taylor NJ, et al. Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis. J Hepatol. 2011; 54(4):640-9. doi: 10.1016/j.jhep.2010.07.045 PMID: 21163546.
15. Tritto G, Bechlis Z, Stadlbauer V, Davies N, Frances R, Shah N, et al. Evidence of neutrophil functional defect despite inflammation in stable cirrhosis. J Hepatol. 2011; 55(3):574-81. doi: 10.1016/j.jhep. 2010.11.034 PMID: 21236309.
16. Van der Rijt CC, Schalm SW, De Groot GH, De Vlieger M. Objective measurement of hepatic encephalopathy by means of automated EEG analysis. Electroencephalogr Clin Neurophysiol. 1984; 57 (5):423-6. PMID: 6201336.
17. Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001; 34(5):768-73. PMID: 11434627.
18. Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Haussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology. 2002; 35(2):357-66. doi: 10.1053/jhep. 2002.30957 PMID: 11826409.
19. Such J, Frances R, Munoz C, Zapater P, Casellas JA, Cifuentes A, et al. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites. Hepatology. 2002; 36(1):135-41. doi: 10.1053/jhep.2002.33715 PMID: 12085357.
20. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001; 33(2):464-70. PMID: 11172350
21. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973; 60(8):646-9. PMID: 4541913.
22. Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014; 60(2):715-35. doi: 10.1002/hep.27210 PMID: 25042402.
23. Montagnese S, Balistreri E, Schiff S, De Rui M, Angeli P, Zanus G, et al. Covert hepatic encephalopathy: agreement and predictive validity of different indices. World J Gastroenterol. 2014; 20(42):15756-62. doi: 10.3748/wjg.v20.i42.15756 PMID: 25400460; PubMed Central PMCID: PMC4229541.
24. Lauridsen MM, Schaffalitzky de Muckadell OB, Vilstrup H. Minimal hepatic encephalopathy characterized by parallel use of the continuous reaction time and portosystemic encephalopathy tests. Metab Brain Dis. 2015. doi: 10.1007/s11011-015-9688-7 PMID: 26016624.
25. Meisel C, Schwab JM, Prass K, Meisel A, Dirnagl U. Central nervous system injury-induced immune deficiency syndrome. Nat Rev Neurosci. 2005; 6(10):775-86. doi: 10.1038/nrn1765 PMID: 16163382.
26. Dirnagl U, Klehmet J, Braun JS, Harms H, Meisel C, Ziemssen T, et al. Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke. 2007; 38(2 Suppl):770-3. doi: 10.1161/01. STR.0000251441.89665.bc PMID: 17261736.
27. Emsley HC, Hopkins SJ. Post-stroke immunodepression and infection: an emerging concept. Infect Disord Drug Targets. 2010; 10(2):91-7. PMID: 20166972.
28. Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med. 2003; 198(5):725-36. doi: 10.1084/jem. 20021098 PMID: 12939340; PubMed Central PMCID: PMC2194193.
29. El Kebir D, Jozsef L, Filep JG. Neutrophil recognition of bacterial DNA and Toll-like receptor 9-dependent and -independent regulation of neutrophil function. Arch Immunol Ther Exp (Warsz). 2008; 56 (1):41-53. doi: 10.1007/s00005-008-0008-3 PMID: 18250968.
30. Etheredge EE, Spitzer JA. Chronic endotoxemia reversibly alters respiratory burst activity of circulating neutrophils. J Surg Res. 1993; 55(3):261-8. doi: 10.1006/jsre.1993.1138 PMID: 8412108.
31. Bohmer RH, Trinkle LS, Staneck JL. Dose effects of LPS on neutrophils in a whole blood flow cytometric assay of phagocytosis and oxidative burst. Cytometry. 1992; 13(5):525-31. doi: 10.1002/cyto. 990130512 PMID: 1321708.
32. Albillos A, de la Hera A, Gonzalez M, Moya JL, Calleja JL, Monserrat J, et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology. 2003; 37(1):208-17. doi: 10.1053/jhep.2003.50038 PMID: 12500206.
33. Cirera I, Bauer TM, Navasa M, Vila J, Grande L, Taura P, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol. 2001; 34(1):32-7. PMID: 11211904.
34. Straub RH, Wiest R, Strauch UG, Harle P, Scholmerich J. The role of the sympathetic nervous system in intestinal inflammation. Gut. 2006; 55(11):1640-9. doi: 10.1136/gut.2006.091322 PMID: 17047110; PubMed Central PMCID: PMC1860105.
35. Newton JL, Hollingsworth KG, Taylor R, El-Sharkawy AM, Khan ZU, Pearce R, et al. Cognitive impairment in primary biliary cirrhosis: symptom impact and potential etiology. Hepatology. 2008; 48 (2):541-9. doi: 10.1002/hep.22371 PMID: 18563843.
36. Worlicek M, Knebel K, Linde HJ, Moleda L, Scholmerich J, Straub RH, et al. Splanchnic sympathectomy prevents translocation and spreading of E coli but not S aureus in liver cirrhosis. Gut. 2010; 59 (8):1127-34. doi: 10.1136/gut.2009.185413 PMID: 20519743.
37. Montagnese S, Biancardi A, Schiff S, Carraro P, Carla V, Mannaioni G, et al. Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis. Hepatology. 2011; 53 (2):558-66. doi: 10.1002/hep.24043 PMID: 21274876.